series-c-plus
Stage
3
Investors
About
StromaCare is a French biotechnology company focused on developing cancer immunotherapies by targeting the tumor stroma to enhance immune system access and efficacy against solid tumors.
Explore StromaCare's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.